QuantiFERON-TB Gold (QFT-G) is a widely used interferon-gamma release assay (IGRA) for diagnosing tuberculosis infection. While generally reliable, false-positive results can occur, presenting a diagnostic challenge that requires careful investigation. Understanding the specific scenarios and biological mechanisms behind a quantiferon gold false-positive outcome is essential for clinicians to avoid misdiagnosis and inappropriate treatment.
Defining a False Positive in the QFT-G Context
A false-positive QFT-G result occurs when a person who does not have a current or past tuberculosis infection tests positive for the assay. This reaction indicates an immune response to the TB-specific antigens used in the test, but that response is not triggered by *Mycobacterium tuberculosis*. The test detects the presence of memory T-cells that recognize these antigens, so a false positive signifies an immunological cross-reactivity or an anomaly in the laboratory process rather than an actual TB infection.
Non-Tuberculous Mycobacterial Exposure
Environmental Mycobacteria
One of the most common causes of a quantiferon gold false-positive result is exposure to non-tuberculous mycobacteria (NTM). These ubiquitous environmental bacteria are found in soil, water, and dust. While distinct from *M. tuberculosis*, they share similar immunogenic proteins. When a person's immune system has been sensitized by NTM, the T-cells targeted by the QFT-G assay may cross-react, leading to a positive test despite the absence of TB infection.
BCG Vaccination Factors
The Bacillus Calmette-Guérin (BCG) vaccine, used primarily in countries with high tuberculosis prevalence, is a frequent contributor to false-positive results. The QFT-G test utilizes specific antigens (ESAT-6 and CFP-10) that are not present in the BCG strain, which generally makes it more specific than the old tuberculin skin test (TST). However, immune responses to antigens other than those targeted by the assay, or rare instances of vaccine strain contamination, can sometimes trigger a positive QFT-G, creating a scenario interpreted as a quantiferon gold false-positive in vaccinated individuals.
Laboratory and Pre-analytical Variables
Technical and Handling Errors
Not all positive results stem from biological cross-reactivity; procedural errors can also lead to a quantiferon gold false-positive outcome. Contamination of the sample with residual proteins from other mycobacteria, improper handling of blood specimens, or issues with the reagents used in the automated T-SPOT reading system can all generate false signals. Rigid adherence to collection protocols and stringent quality control in the laboratory are critical to minimizing this category of error.
Immune System Cross-Reactivity
The human immune system is complex, and its memory cells can recognize similar molecular patterns across different microbial species. Beyond NTM and BCG, other infections—such as infections with *Salmonella* species or the presence of autoimmune disorders—might theoretically stimulate T-cells that react with the TB antigens in the QFT-G kit. While less common, this immunological "cross-talk" represents a biological basis for a quantiferon gold false-positive result, particularly in patients with compromised or hyperactive immune systems.
Rare Biological and Medical Conditions
In very rare instances, physiological states can interfere with the assay mechanics. Conditions that cause transient bacteremia or the presence of atypical mycobacteria in the body can stimulate an immune response that the test detects as positive. Furthermore, individuals receiving certain immunomodulatory therapies might have altered cytokine expression that impacts the ELISPOT reading, potentially manifesting as a false signal that mimics a true positive infection.
